Politician trade (House)

Steris (STE)Rep. Jared Moskowitz (FL23) disclosed a sale $1K–$15K

Rep. Jared Moskowitz (FL23) disclosed a sale of Steris in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
45 days
Disclosure lag
Traded
Jul 13, 2026
Disclosed
Aug 27, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 7, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On July 31, 2026, Pierre Boulud was appointed to serve on the Audit Committee of the Board and the Compliance and Technology Committee of the Board.”
  2. May 11, 2026Congress · 1 personMembers of Congress: 2 purchases
  3. May 13, 2026CongressDisclosed purchase of STE — reported range $1,001 - $15,000
  4. May 15, 2026FDARecall: HarmonyAIR A-Series Surgical Lighting System
  5. May 15, 2026FDARecall: HarmonyAIR A-Series Surgical Lighting System
  6. May 15, 2026FDARecall: ALYON Surgical Lighting System
  7. Jun 2, 2026InsiderDirector sold ~$310K of STE shares in the open market
  8. Jun 4, 2026InsiderCEO sold ~$656K of STE shares in the open market
  9. Jun 5, 2026InsiderCEO sold ~$291K of STE shares in the open market
  10. Jun 15, 2026InsiderOfficer sold ~$297K of STE shares in the open market
  11. Jun 24, 2026FDAFDA device clearance: AMSCO 700 Steam Sterilizer
  12. Jul 13, 2026 · this disclosureCongressDisclosed sale of STE — reported range $1,001 - $15,000

What came next

  1. Jul 24, 2026CongressDisclosed partial sale of STE — reported range $1,001 - $15,000
  2. Jul 27, 2026CongressDisclosed partial sale of STE — reported range $1,001 - $15,000
  3. Jul 29, 2026CongressDisclosed partial sale of STE — reported range $1,001 - $15,000
  4. Jul 31, 2026CongressDisclosed partial sale of STE — reported range $1,001 - $15,000
  5. Aug 5, 2026Company filing · Form 8-K · Results, RestructuringAnnounced job cuts, closures or a restructuring, and reported its results“On August 5, 2026, the Company announced a targeted consolidation plan (the “Consolidation Plan”) to consolidate existing manufacturing and distribution for formulated chemistries to a new Center of Excellence in North Carolina.”
  6. Aug 12, 2026InsiderDirector sold ~$957K of STE shares in the open market
  7. Aug 25, 2026CongressDisclosed sale of STE — reported range $100,001 - $250,000
  8. Sep 15, 2026CongressDisclosed sale of STE — reported range $15,001 - $50,000
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Steris

For Steris, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 7 Congress trade reports and 18 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its STE page.

Other recent filings by Rep. Jared Moskowitz (FL23)

The full history of Rep. Jared Moskowitz (FL23) is on the profile page.

How this filing works

Other disclosures at Steris

Everything OQRO holds on this company is on its STE page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data